With a strong background in venture capital, the fund manager has successfully completed over 50 deals, primarily in technology and healthcare sectors. Active in both North America and Europe, their focus lies on early-stage investments, emphasizing an operator-first strategy that leverages deep industry insights. Noteworthy exits include several high-profile companies that have achieved substantial market recognition. Their approach is data-driven, aiming to identify thematic opportunities that align with emerging trends and innovations.